Reciprocal Influences of HIV and Cannabinoids on the Brain and Cognitive Function

被引:0
作者
Sheri L. Towe
Christina S. Meade
Christine C. Cloak
Ryan P. Bell
Julian Baptiste
Linda Chang
机构
[1] Duke University School of Medicine,Department of Psychiatry & Behavioral Sciences
[2] University of Maryland School of Medicine,Diagnostic Radiology and Nuclear Medicine
[3] Johns Hopkins University School of Medicine,Department of Neurology
[4] University of Hawaii at Manoa,John A Burns School of Medicine
来源
Journal of Neuroimmune Pharmacology | 2020年 / 15卷
关键词
HIV; Endocannabinoid system; Cannabis; Neuropathogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
Globally, cannabis is the most commonly used illicit drug, with disproportionately high use among persons with HIV. Despite advances in HIV care, nearly half of persons living with HIV continue to experience neurocognitive deficits or impairments that may have negative impacts on their daily function. Chronic cannabis use may play a role in the development or exacerbation of these impairments. Here we present a review summarizing existing research detailing the effect of cannabis use associated with the neuropathogenesis of HIV. We examine evidence for possible additive or synergistic effects of HIV infection and cannabis use on neuroHIV in both the preclinical and adult human literatures, including in vitro studies, animal models, clinical neuroimaging research, and studies examining the cognitive effects of cannabis. We discuss the limitations of existing research, including methodological challenges involved with clinical research with human subjects. We identify gaps in the field and propose critical research questions to advance our understanding of how cannabis use affects neuroHIV.
引用
收藏
页码:765 / 779
页数:14
相关论文
共 252 条
  • [1] Abrams DI(2007)Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial Neurology 68 515-521
  • [2] Aizpurua-Olaizola O(2016)Evolution of the cannabinoid and terpene content during the growth of J Nat Prod 79 324-331
  • [3] Ances BM(2014) plants from different chemotypes Curr Opin HIV AIDS 9 545-24
  • [4] Hammoud DA(2017)Neuroimaging of HIV associated neurocognitive disorders (HAND) Neuropharmacology 124 13-1074
  • [5] Araque A(2008)Synaptic functions of endocannabinoid signaling in health and disease Neuroimage 41 1067-479
  • [6] Castillo PE(2010)Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics Br J Pharmacol 160 467-4614
  • [7] Manzoni OJ(2015)CB2: a cannabinoid receptor with an identity crisis Br J Clin Pharmacol 172 4603-479
  • [8] Tonini R(2014)Impaired neurogenesis by HIV-1-Gp120 is rescued by genetic deletion of fatty acid amide hydrolase enzyme Br J Clin Pharmacol 171 468-35
  • [9] Arnone D(2015)The cannabinoid CB(2) receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis Dev Cogn Neurosci 16 23-2536
  • [10] Barrick TR(2005)Longitudinal changes in white matter microstructure after heavy cannabis use J Neurosci 25 2530-567